The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Oncol
Huvudupphovsmän: Lopez-Beltran, Antonio, Henriques, Vanessa, Cimadamore, Alessia, Santoni, Matteo, Cheng, Liang, Gevaert, Thomas, Blanca, Ana, Massari, Francesco, Scarpelli, Marina, Montironi, Rodolfo
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2018
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://ncbi.nlm.nih.gov/pubmed/30450335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk